U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551440) titled 'Identification of Therapeutic Targets in Metastatic Gastric Cancer' on Aug. 10, 2023.
Brief Summary: This is a pilot study aiming at identifying novel therapeutic molecular targets in patients with gastric cancer with lymph nodes or distant metastasis. All patients who are diagnosed with gastric cancer with metastases in the Prince of Wales Hospital will be screened for eligibility.
Study Start Date: Oct. 15, 2023
Study Type: OBSERVATIONAL
Condition:
Stomach Neoplasms, Benign
Recruitment Status: RECRUITING
Sponsor: Chinese University of Hong Kong
Information provided by (Responsible Party): CHAN SHANNON MELISSA, Chinese Univ...